Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07660536 · ClinicalTrials.gov registry record · Phase 2
To Study the Efficacy and Safety of Doxercalciferol on Spinal and Femoral Density in Postmenopausal Osteopenic Women in a Long Term 2 Year Study
A Phase 2 study, sponsored by Creighton University.
- Completed
- Registry status
- Phase 2
- Development phase
- 60
- Enrollment target
NCT07660536 is a Phase 2 study that has completed, run by Creighton University. The registered enrollment target is 60 participants.
The verdict
NCT07660536, a Phase 2 study, has completed, sponsored by Creighton University.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 60 participants
- Enrollment target
Study Summary
A clinical trial to compare the effect of doxercalciferol or placebo in preventing bone loss from the spine and femur in postmenopausal women
Interventions
- DRUG doxercalciferol capsules, Hectorol®
- DRUG Matched Placebo (Capsules)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 1989-11-14 |
| Est. Completion | 1994-12-23 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07660536
The ClinicalTrials.gov registry entry for NCT07660536 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Creighton University, which has 98 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which doxercalciferol capsules, Hectorol® is the first listed.
NCT07660536 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07660536 about?
NCT07660536 is a clinical study titled "To Study the Efficacy and Safety of Doxercalciferol on Spinal and Femoral Density in Postmenopausal Osteopenic Women in a Long Term 2 Year Study". A clinical trial to compare the effect of doxercalciferol or placebo in preventing bone loss from the spine and femur in postmenopausal women
What is the current status of trial NCT07660536?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 60 participants. The study started on 1989-11-14. Estimated completion is 1994-12-23.
What interventions are being tested in trial NCT07660536?
The interventions under investigation include: doxercalciferol capsules, Hectorol® (DRUG), Matched Placebo (Capsules) (DRUG).
Who is sponsoring clinical trial NCT07660536?
This trial is sponsored by Creighton University, which has 98 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.